886 research outputs found

    Bacterial leakage around dental restorations: its effect on the dental pulp

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/72129/1/j.1600-0714.1982.tb00188.x.pd

    Metronidazole in Periodontitis: I. Clinical and Bacteriological Results after 15 to 30 Weeks

    Full text link
    Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/141752/1/jper0325.pd

    The in-vitro effect of fungal dextranase on human dental plaque

    Full text link
    Suspensions of dental plaque from eighteen children with high caries activity were hydrolyzed in vitro by a partially purified fungal dextranase isolated from Penicillium funiculosum NRRL 1768. The dextranase preparation appeared to lack 1,4-glucanhydrolase and sucrase activity. The release of reducing substances from the plaque was measured by use of a 3,5-dinitrosalicylate reagent. Hydrolysis occurred at pH 5.1 but not at pH 7.0. Approximately 20 per cent of the total carbohydrate of plaque was consumed by the dextranase (2-3 per cent of the plaque dry weight). No isomaltose was found when the hydrolysates were analysed by a thin layer chromatography procedure which could detect as little as 0.1 [mu]g of isomaltose. The findings suggest that the quantity of dextran in these plaque samples is low.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/34184/1/0000473.pd

    The effects of periodontal therapy on serum antibody (IgG) levels to plaque microorganisms *

    Full text link
    The influence of periodontal therapy on serum antibody titers to selected periodontal disease-associated microorganisms was assessed in 23 patients having chronic inflammatory periodontal disease (CIPD), The immunoglobulin G (IgG) titers were dÉtÉrmined by the micro ELISA technique in serum samples obtained prior to treatment; following a hygienic phase which included scaling, root planing, and oral hygiene instruction; following surgical treatment; and one year and two years following hygienic phase (maintenance phase). Considerable individual variability existed in the magnitude of immune response to specific bacterial preparations. Significant reductions in the mean antibody titers were seen to A. viscosus. S. sanguis. F. nucleatum, S, spuligena, B. gingivalis. B. interme-dius. B. melaninogeniem, T. vincentii , and T denticola by the end of the second year of maintenance. There was no consistent response to Capnucytophaga. When individual patient responses were examined. 6 of the 23 were found to have elevated titers to at least one of the microorganisms in the interval between pretreatment and the end of the hygienic phase; however, in all but one case, the titers at the end of the second year of maintenance were below pretreatment levels. Antibody levels to bacteria such as S. sanguis were modified during therapy. This would indicate that immune responses to microbes not generally considered to be “periodontal pathogens” may be modified by adjuvant activity associated with subgingival plaque or changes in the environment of the sulcus and that subsequent changes in titer do not necessarily reflect a role of that microorganism in the disease process.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/75110/1/j.1600-051X.1988.tb02127.x.pd

    Efficiency of split-mouth designs

    Full text link
    . The purpose of this paper is (1) to investigate the similarity of the amount, distribution, and, severity of periodontal disease of the within-patient experimental units, (2) to estimate the relative efficiencies of split-mouth designs when compared to whole-mouth designs, and (3) to discuss how stratification on initial pocket depth can result in large differences in the power of the test-statistics in the different disease categories. Periodontal disease characteristics are not always homogeneously distributed over the within-patient experimental units and this heterogeneity can reduce the efficiency of split-mouth designs. In particular, if analyses are stratified on initial pocket depth, sites with an initial probing depth deeper than 6 mm may be small in number and asymmetrically distributed when compared to sites with an initial probing depth less than 6 mm. This may result in large differences of the power of the test statistics among the different disease categories and should lead to a careful interpretation of the statistical significance tests. When disease characteristics are symmetrically distributed over the within-patient experimental units and a sufficient number of sites is present per experimental unit, the split-mouth design can provide moderate to large gains in relative efficiency. In the absence of a symmetric disease distribution, wholemouth clinical trials may be preferable.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/75701/1/j.1600-051X.1990.tb01060.x.pd
    corecore